ABSTRACT
INTRODUCTION
Late onset Hypogonadism (LOH) [1] also sometimes called Partial Androgen Decline in Aging Males (PADAM) or Androgen Decline in Aging Males (ADAM) [2] describes the gradual decline in androgen production in men, sometimes accompanied by a number of rather subtle symptoms including gradual loss of muscle strength and bone density, decrease in libido, memory, enjoyment of life and mood, as well as impotence, asthenia and cognitive dysfunctions [3] [4] [5] . Recognition of LOH is frequently obscured by signs of natural ageing enhanced by "male climacteric" factors.
The production of testicular testosterone gradually decreases with age in men but this decrease is more individually variable [6] and is not as readily evident or abrupt as the estrogen decrease seen in women during the climacteric period. In normally aging men, total testosterone and albumin-bound testosterone concentrations in serum decline, whereas sex hormone binding globulin usually increases [7] . This leads to a more readily observable decrease in circulating free or bio-available testosterone (BT) than in total testosterone (T) [6] .
In a cross-sectional Swedish study performed in 2003, we investigated probable symptoms of LOH and associated them with hormone concentrations [8] . We found that symptoms associated with LOH often occur in an elderly population, but that only three symptoms were associated with low blood testosterone concentrations: "deterioration in work performance, decreased strength and bothersome hot flushes". Also in line with previous reports [9], 4.5% of men reported hot flushes, which is why we suggest that hot flushes should be regarded as a possible LOH symptom. There are also other studies [10, 11] that have failed to identify a connection between LOH symptoms and circulating androgen levels. To monitor changes in LOH symptoms as well as androgens, we used the same cross-sectional study design as in 2003 in the same cohort of men but five years later.
The objectives of this study were; 4 
1)
to assess the prevalence of different symptoms associated with LOH including hot flushes and to correlate these symptoms with sex steroid concentrations, and 2) to compare the results with the results from the study performed 5 years earlier [8] and to assess by means of a questionnaire whether changes in sex steroid (T and BT) concentrations were associated with certain symptoms. 5 by reported length and weight from the questionnaire.
METHODS

This is
The questionnaire was designed to make it as easy as possible for the subjects to answer so that all that had to be done was to make a tick mark in the series of boxes. The questionnaire was slightly modified from a previously used and validated questionnaire developed by us [9, 12] . Reproducibility was tested by Spetz et al. 2007 [8] .
The ADAM-questionnaire
Morley et al. have validated the use of the ADAM-questionnaire, as a means of screening for individuals with possible low levels of BT [13, 14] . The 10 questions from the ADAM-questionnaire were translated into Swedish and scattered throughout the questionnaire. According to Morley and coworkers, answering "yes" to item 1 or 7 or "yes" to any other three questions predicts low BT with a sensitivity of 88% and a specificity of 60% [14] . We chose, however, to create an additional score;
"ADAM-positivity and -negativity", where men positive for the ADAM-questionnaire (answering 6 "yes" to item 1 or 7 or "yes" to any other three questions or more) were classified as "ADAM-positive", and the others were "ADAM-negative" [8] . We also developed a term called "ADAM-sum", according to the number of "yes" replies in the questionnaire. One to three "yes" is called "low ADAM-sum", four to six "yes" is called "medium ADAM-sum" and seven to ten "yes" "high ADAM-sum", i.e. we did not give the answers to questions 1 or 7 any special attention [8] .
Data handling
The questionnaires were coded only in order to be able send a reminder to the subjects. All information from the answered questionnaires was optically scanned and exported to SPSS for Windows. The agreement between optical and manual reading was checked for the first ten complete questionnaires and the optical reading was continued only after the manual and the optical reading agreed totally. All information was handled confidentially. All data were analysed by using SPSS 14. 
Laboratory investigations:
Fed morning serum samples from 329 of the 370 men (all centers except for one of the Primary Health Centre) were analysed as follows. Albumin was analysed using Immunochemistry (Advia 1800, Siemens Medical Solutions Diagnostics, Sweden). Testosterone and SHBG were measured using timeresolved fluorometry immunoassay AutoDelfia 1235, Perkin Elmer Life and Analytical Science, Sweden). Almost all analyses were made at the department of Clinical Chemistry, University Hospital, Linkoping, Sweden using the same methods as in 2003 [8] .
Fed morning serum samples from 41 men from one of the three different Primary Health Care Centres, were analysed as follows. Albumin was measured using a spectrophotometric bromcresolgreen-method BT was calculated based on concentrations of Testosterone, Albumin, and SHBG according to an algorithm previously described [15] .
Ethics
All data were handled confidentially. The study was approved by the Regional Ethical Committee at the Faculty of Health Sciences, Linkoping University. 8 
RESULTS
In total 282 questionnaires were sent out. After one reminder, 249 questionnaires were returned, three of which were not filled in, making 246 questionnaires (87.2 %) eligible for evaluation. Thirteen men had been treated by castration, but their questionnaires were not excluded from analyses since their answers did not differ much from the "average-answered" questionnaires. The median age of the men was 68.4 years (YY) (range 60-82 YY; SD 5.73YY). We split the men into three different age groups, the same men in each group as in 2003. Demographic data are presented in table I.
Ninety-six men (54% ) used medication for hypertension and/or cardiac disease. Thirty-nine men used a low dose of acetylsalicylic acid, twelve men used warfarin and 45 men used blood-lipid-lowering medication. Psychoactive drugs, e.g. selective serotonin reuptake inhibitors (SSRI) and serotonin and norepinephrine reuptake inhibitors (SNRI) were used by seven men whereas none used benzodiazepines. Sleeping pills were used by five men. Six men used chronic medication for pain- There was no significant difference between levels of BT and T according to reported alcoholic intake or between smokers and non-smokers.
Exercise habits and the muscular/skeletal system
Type and frequency of exercise habits are presented in Table I . Men who exercised > 12 h/month (74.4%) had higher concentrations of T (mean 15.4 nmol/L) than those who exercised less (T= 12.9 nmol/L; p=0.0291), whereas BT did not differ between these groups.
The ADAM-questionnaire and other possible symptoms of LOH
Five of the symptoms listed in the ADAM-questionnaire were more common in the older age groups than in the younger/youngest; i.e. "decrease in libido", "lack of energy", "decreased strength and/or 9 endurance", "less strong erections" and "deterioration in work performance" (p<0.05). Three of ten symptoms were associated with low BT and T (Table II) . In the youngest age group, T was lower in men who reported decreased enjoyment of life and in men who reported sadness and/or grumpiness than in men who did not express these complaints (p=0.017 and 0.025, respectively). None of the other symptoms from the ADAM-questionnaire were significantly connected with low concentrations of T and BT.
Medication to deal with problems experienced during intercourse was tried by 11.2% of the men showing no differences between age-groups. "Decreased need to shave" was more commonly reported by the oldest men than by men in age group II (p< 0.001).
83.7 % of all men were "ADAM-positive", significantly more in the older age-groups than in the youngest (p<0.05). "ADAM-positive" men had lower T and BT than "ADAM-negative" men (p=0.003
and 0.023 respectively), whereas SHBG did not differ. Men with "low ADAM-sum" had higher T and BT than men with higher "ADAM-sum" (Figure 2 ). ADAM-sum was lower in the youngest age-group than in the others (p=0.001). 54.4% in the youngest group and 29.1% and 26.7% in the older agegroups had "low ADAM-sum". A high ADAM-sum was more common in age-groups II and III, (27.9% and 22.7%) than in the youngest age group (p=0.00).
Hot flushes 3 .7% of men reported hot flushes at least a few times weekly. In total, 26.9% reported hot flushes.
Of men reporting hot flushes 54% were bothered by them, and 18% suffered moderately to severely.
There was no difference between T and BT concentrations either between age groups or between men who reported and/or suffered from hot flushes and those who did not.
There was no significant difference in the prevalence of hot flushes between those men who exercised more than 12 hours per month and those who exercised less or between men who used alcohol once a week and men who used alcohol once a month or less. Hot flushes were more prevalent in men who used psychoactive drugs, e.g. sleeping pills (5 men), SSRI/SNRI (7 men) than in non-users (62.6% compared to 12.6%; p<0.0001) and also suffering from them was also more prevalent in men who used psychoactive drugs (36.8% and 12.9%, respectively, p=0.009). T and BT concentrations did not differ between these two groups. (Table III) .
DISCUSSION
As in the former study [8] BT-and T-concentrations did not differ between age-groups. However, as burden) had higher concentrations of BT and/or T than men with medium and high "ADAM-sum in both studies [8] . 84% of the men were "ADAM-positive", more in the oldest age-group than in the others. The same was reported in 2003 (85%) [8] . However, in the current study we also found that 11 "ADAM-positive" men had lower BT-and T-concentrations, supporting the results from Morley et al [14] .
Interestingly, we found higher loss of BT and/or T concentrations over five years in men reporting some specific symptoms for the first time in 2008 than in men who reported the same or fewer symptoms in 2008 than in 2003. We interpret this as a change in BT and T is a better predictor of symptom development than the actual level of T or BT. It must be kept in mind, however, that there are many factors other than low testosterone that can cause almost the same symptoms. As discussed by Wang et al [1] , it is difficult to diagnose LOH since many of the symptoms indicating LOH can occur in connection with other diseases and as a result of ageing alone.
Hot flushes were reported by more than every fourth man, and half of them said that they suffered from the flushes. This is in line with our earlier studies on aging men [8, 9] . However, flushes occurring more often than once a week are still reported only by a minority, 3.7% in this report, and 4.5% in the former study [8] . We have previously suggested that hot flushes should be considered for incorporation in the set of symptoms of LOH [8] , because hot flushes are common in men and women deprived of sex steroids, i.e. men treated by castration due to prostate cancer and menopausal women [18, 19] .
The clinical entities LOH, PADAM, and "andropause" are still controversial. McKinley et al [16] asked for a "decent burial" of this controversy, since they stated that the issue has been repeatedly examined and shows little evidence of life. It is well known that testosterone concentrations decrease with age in healthy aging men, but still there are men that keep their testosterone production almost intact throughout their lifespan and who are reproductive even in old age [17] . However, most men have decreasing testosterone production as a consequence of testicular failure and low activity in the gonadal-hypophyseal-hypothalamic axis, some with symptoms of LOH and some without.
Unfortunately, due to technical problems at one of the primary health care centres, blood samples from 41 men were not sent for analyses to the department of Clinical Chemistry, University
Hospital of Linkoping, but instead were analysed at the local Clinical Chemistry laboratory using other methods. However, between 30 and 48 natural patient samples were analysed by both methods and used to re-calibrate and re-calculate the results from these 41 samples in the study in a reliable manner. 12 The response rate of 87% is very satisfying for this kind of study. The men were, in addition to being offered contact with their doctor, also informed of the results from the study in 2003, which may have made them more prone to answer the questionnaire once again.
In the current study three of ten symptoms, from the ADAM-questionnaire; "lack of energy", deterioration of work-performance" and "decreased strength and/or endurance", were associated with Table III) . One of these symptoms was "loss in libido". Also "less strong erections", "lack of energy" and "deterioration in work-performance" showed the same tendencies, the first two symptoms seen to be associated with a low serum testosterone level may raise suspicion of testosterone deficiency, according to Wang et al [1] .
One interesting question was whether men diagnosed with prostate cancer after the study from 2003 [8] , might have had higher T-or BT-concentrations than the other men in the study from 2003. We were, however, not able to confirm this.
The clinical entity LOH is still controversial, since it is very difficult to sort out if it is age per se or the partial androgen insufficiency that gives rise to the different symptoms associated with the entity [1, 20, 21] . This study did not find any strong correlation between LOH symptoms and circulating testosterone concentrations. Others have previously attempted to create symptom scores based on answers to questionnaires, for example the ADAM [14] questionnaire and the Aging Male Survey, that are highly sensitive, but nevertheless have suboptimal specificity. Recently, Morley suggested that a combination of symptoms and testosterone measurement is inadequate to make the diagnosis of LOH.
According to him the diagnosis can only be stated when there are symptoms, low testosterone and amelioration of symptoms within a three months period of testosterone therapy [22] . Wang et al [1] , recommend a structured scheme built on evidence and grades and stated that low libido is the most common symptom associated with LOH [1] . In this study, many symptoms were reported to be more showed that a few symptoms, including low libido and less strong erections were more common, suggesting that the changes in the T-and BT-concentrations over the years might be more important than the actual concentration measured at the specific moment. It also became evident that a combination of different symptoms seems to predict the suspicion of LOH better than single symptoms.
In conclusion, we were not able to find a new, more easily useable instrument to identify LOH, even though using a complex of suggested symptoms seems to be more reliable than using any single symptom. However, we believe that it is the magnitude of the loss, rather than the actually measured concentrations of T and or BT, that seems to be more crucial in indicating the occurrence of symptoms of LOH. The LOH-entity is very complex and every patient has to be taken care of individually with special care being given to the individual patient's medical history and lifestyle. Table I : Demographic data on men answering the specific questions (mean +/-SD or percentage). Answers to every item were not given in all questionnaires. Table II -
Symptoms from the ADAM-questionnaire that is associated with lower T-and BT-concentrations (nmol/L). 
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